Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


Articles published in Eur Radiol

Retrieve available abstracts of 33 articles:
HTML format
Text format



Single Articles


    February 2019
  1. BLANKS RG, Given-Wilson RM, Cohen SL, Patnick J, et al
    An analysis of 11.3 million screening tests examining the association between recall and cancer detection rates in the English NHS breast cancer screening programme.
    Eur Radiol. 2019 Feb 4. pii: 10.1007/s00330-018-5957.
    PubMed     Text format     Abstract available


    January 2019
  2. HAN L, Zhu Y, Liu Z, Yu T, et al
    Radiomic nomogram for prediction of axillary lymph node metastasis in breast cancer.
    Eur Radiol. 2019 Jan 30. pii: 10.1007/s00330-018-5981.
    PubMed     Text format     Abstract available


  3. FAN M, Zhang P, Wang Y, Peng W, et al
    Radiomic analysis of imaging heterogeneity in tumours and the surrounding parenchyma based on unsupervised decomposition of DCE-MRI for predicting molecular subtypes of breast cancer.
    Eur Radiol. 2019 Jan 7. pii: 10.1007/s00330-018-5891.
    PubMed     Text format     Abstract available


    November 2018
  4. XIE T, Zhao Q, Fu C, Bai Q, et al
    Differentiation of triple-negative breast cancer from other subtypes through whole-tumor histogram analysis on multiparametric MR imaging.
    Eur Radiol. 2018 Nov 6. pii: 10.1007/s00330-018-5804.
    PubMed     Text format     Abstract available


  5. WARD L, Heller S, Hudson S, Wilkinson L, et al
    Parenchymal pattern in women with dense breasts. Variation with age and impact on screening outcomes: observations from a UK screening programme.
    Eur Radiol. 2018;28:4717-4724.
    PubMed     Text format     Abstract available


    October 2018
  6. LAMEIJER JRC, Coolen AM, Voogd AC, Strobbe LJ, et al
    Frequency and characteristics of contralateral breast abnormalities following recall at screening mammography.
    Eur Radiol. 2018;28:4205-4214.
    PubMed     Text format     Abstract available


    September 2018
  7. BOTSIKAS D, Bagetakos I, Picarra M, Da Cunha Afonso Barisits AC, et al
    What is the diagnostic performance of 18-FDG-PET/MR compared to PET/CT for the N- and M- staging of breast cancer?
    Eur Radiol. 2018 Sep 28. pii: 10.1007/s00330-018-5720.
    PubMed     Text format     Abstract available


  8. TARON J, Fleischer S, Preibsch H, Nikolaou K, et al
    Background parenchymal enhancement in pregnancy-associated breast cancer: a hindrance to diagnosis?
    Eur Radiol. 2018 Sep 18. pii: 10.1007/s00330-018-5721.
    PubMed     Text format     Abstract available


  9. BOSS A
    Editorial comment: cone-beam and phase contrast CT: new horizons in breast imaging?
    Eur Radiol. 2018;28:3729-3730.
    PubMed     Text format     Abstract available


  10. WIENBECK S, Fischer U, Luftner-Nagel S, Lotz J, et al
    Contrast-enhanced cone-beam breast-CT (CBBCT): clinical performance compared to mammography and MRI.
    Eur Radiol. 2018;28:3731-3741.
    PubMed     Text format     Abstract available


    August 2018
  11. JOUKAINEN S, Masarwah A, Kononen M, Husso M, et al
    Feasibility of mapping breast cancer with supine breast MRI in patients scheduled for oncoplastic surgery.
    Eur Radiol. 2018 Aug 17. pii: 10.1007/s00330-018-5681.
    PubMed     Text format     Abstract available


  12. SUO S, Zhang D, Cheng F, Cao M, et al
    Added value of mean and entropy of apparent diffusion coefficient values for evaluating histologic phenotypes of invasive ductal breast cancer with MR imaging.
    Eur Radiol. 2018 Aug 16. pii: 10.1007/s00330-018-5667.
    PubMed     Text format     Abstract available


  13. ROSSI F, Valdora F, Barabino E, Calabrese M, et al
    Muscle mass estimation on breast magnetic resonance imaging in breast cancer patients: comparison between psoas muscle area on computer tomography and pectoralis muscle area on MRI.
    Eur Radiol. 2018 Aug 7. pii: 10.1007/s00330-018-5663.
    PubMed     Text format     Abstract available


    July 2018
  14. VAN ZELST JCM, Tan T, Clauser P, Domingo A, et al
    Dedicated computer-aided detection software for automated 3D breast ultrasound; an efficient tool for the radiologist in supplemental screening of women with dense breasts.
    Eur Radiol. 2018;28:2996-3006.
    PubMed     Text format     Abstract available


    June 2018
  15. MATHIEU MC, Toullec A, Benoit C, Berry R, et al
    Preclinical ex vivo evaluation of the diagnostic performance of a new device for in situ label-free fluorescence spectral analysis of breast masses.
    Eur Radiol. 2018;28:2507-2515.
    PubMed     Text format     Abstract available


  16. SCHAEFGEN B, Heil J, Barr RG, Radicke M, et al
    Initial results of the FUSION-X-US prototype combining 3D automated breast ultrasound and digital breast tomosynthesis.
    Eur Radiol. 2018;28:2499-2506.
    PubMed     Text format     Abstract available


  17. HU Y, Yang Y, Gu R, Jin L, et al
    Does patient age affect the PPV3 of ACR BI-RADS Ultrasound categories 4 and 5 in the diagnostic setting?
    Eur Radiol. 2018;28:2492-2498.
    PubMed     Text format     Abstract available


  18. ROMERO MARTIN S, Raya Povedano JL, Cara Garcia M, Santos Romero AL, et al
    Prospective study aiming to compare 2D mammography and tomosynthesis + synthesized mammography in terms of cancer detection and recall. From double reading of 2D mammography to single reading of tomosynthesis.
    Eur Radiol. 2018;28:2484-2491.
    PubMed     Text format     Abstract available


    May 2018
  19. MALL S, Noakes J, Kossoff M, Lee W, et al
    Can digital breast tomosynthesis perform better than standard digital mammography work-up in breast cancer assessment clinic?
    Eur Radiol. 2018 May 30. pii: 10.1007/s00330-018-5473.
    PubMed     Text format     Abstract available


  20. CHEN BB, Lu YS, Yu CW, Lin CH, et al
    Imaging biomarkers from multiparametric magnetic resonance imaging are associated with survival outcomes in patients with brain metastases from breast cancer.
    Eur Radiol. 2018 May 16. pii: 10.1007/s00330-018-5448.
    PubMed     Text format     Abstract available


  21. VAN DER VELDEN BHM, Sutton EJ, Carbonaro LA, Pijnappel RM, et al
    Contralateral parenchymal enhancement on dynamic contrast-enhanced MRI reproduces as a biomarker of survival in ER-positive/HER2-negative breast cancer patients.
    Eur Radiol. 2018 May 7. pii: 10.1007/s00330-018-5470.
    PubMed     Text format     Abstract available


  22. WATANABE G, Itoh M, Duan X, Watabe H, et al
    (18)F-fluorodeoxyglucose specimen-positron emission mammography delineates tumour extension in breast-conserving surgery: Preliminary results.
    Eur Radiol. 2018;28:1929-1937.
    PubMed     Text format     Abstract available


    April 2018
  23. KIM JY, Kim JJ, Kim S, Choo KS, et al
    Diffusion tensor magnetic resonance imaging of breast cancer: associations between diffusion metrics and histological prognostic factors.
    Eur Radiol. 2018 Apr 30. pii: 10.1007/s00330-018-5429.
    PubMed     Text format     Abstract available


  24. KIM WH, Cho N, Kim YS, Yi A, et al
    Mammographic density changes following discontinuation of tamoxifen in premenopausal women with oestrogen receptor-positive breast cancer.
    Eur Radiol. 2018 Apr 6. pii: 10.1007/s00330-017-5293.
    PubMed     Text format     Abstract available


    March 2018
  25. SANABRIA SJ, Goksel O, Martini K, Forte S, et al
    Breast-density assessment with hand-held ultrasound: A novel biomarker to assess breast cancer risk and to tailor screening?
    Eur Radiol. 2018 Mar 19. pii: 10.1007/s00330-017-5287.
    PubMed     Text format     Abstract available


  26. KIM SY, Shin J, Kim DH, Kim EK, et al
    Correlation between electrical conductivity and apparent diffusion coefficient in breast cancer: effect of necrosis on magnetic resonance imaging.
    Eur Radiol. 2018 Mar 6. pii: 10.1007/s00330-017-5291.
    PubMed     Text format     Abstract available


    January 2018
  27. KIM SY, Cho N, Shin SU, Lee HB, et al
    Contrast-enhanced MRI after neoadjuvant chemotherapy of breast cancer: lesion-to-background parenchymal signal enhancement ratio for discriminating pathological complete response from minimal residual tumour.
    Eur Radiol. 2018 Jan 29. pii: 10.1007/s00330-017-5251.
    PubMed     Text format     Abstract available


  28. LI X, Gao H, Chen Z, Zhang L, et al
    Diagnosis of breast cancer based on microcalcifications using grating-based phase contrast CT.
    Eur Radiol. 2018 Jan 26. pii: 10.1007/s00330-017-5158.
    PubMed     Text format     Abstract available


  29. HORVAT JV, Durando M, Milans S, Patil S, et al
    Apparent diffusion coefficient mapping using diffusion-weighted MRI: impact of background parenchymal enhancement, amount of fibroglandular tissue and menopausal status on breast cancer diagnosis.
    Eur Radiol. 2018 Jan 12. pii: 10.1007/s00330-017-5202.
    PubMed     Text format     Abstract available


    December 2017
  30. RODRIGUEZ-RUIZ A, Gubern-Merida A, Imhof-Tas M, Lardenoije S, et al
    One-view digital breast tomosynthesis as a stand-alone modality for breast cancer detection: do we need more?
    Eur Radiol. 2017 Dec 11. pii: 10.1007/s00330-017-5167.
    PubMed     Text format     Abstract available


    November 2017
  31. MOSHINA N, Roman M, Waade GG, Sebuodegard S, et al
    Breast compression parameters and mammographic density in the Norwegian Breast Cancer Screening Programme.
    Eur Radiol. 2017 Nov 2. doi: 10.1007/s00330-017-5104.
    PubMed     Text format     Abstract available


    October 2017
  32. ZHAO J, Zhang J, Zhu QL, Jiang YX, et al
    The value of contrast-enhanced ultrasound for sentinel lymph node identification and characterisation in pre-operative breast cancer patients: A prospective study.
    Eur Radiol. 2017 Oct 20. doi: 10.1007/s00330-017-5089.
    PubMed     Text format     Abstract available


  33. GIROMETTI R, Zanotel M, Londero V, Linda A, et al
    Automated breast volume scanner (ABVS) in assessing breast cancer size: A comparison with conventional ultrasound and magnetic resonance imaging.
    Eur Radiol. 2017 Oct 10. doi: 10.1007/s00330-017-5074.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: